Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
about
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.Pain in cancer survivorsLong-term consequences of hematopoietic stem cell transplantation: current state of the science.Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concernsPredictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.A framework for assessment in oncology rehabilitation.Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challengesAdverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantationDevelopment and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantationArrhythmias in the setting of hematopoietic cell transplants.Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumorsCause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor StudyGenetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children.Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patient.Cardiovascular Complications of Hematopoietic Stem Cell Transplantation.Late congestive heart failure after hematopoietic cell transplantationLong-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.Cardiovascular disease in survivors of hematopoietic cell transplantation.Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients.Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT.Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation.Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
P2860
Q30449589-DAE481CD-E357-4EE7-87AA-EE345EE5923EQ33650576-DA7E97F2-865C-454F-B302-B855BDCC9112Q33705877-1B4A296A-068B-479A-A6C8-1171063585E5Q33754654-4D311845-5756-4B70-BFB1-CC516CA5C316Q33926274-69A348E1-18E9-44FC-BE48-66CC987E969DQ34091836-1C8CA0D1-FF44-487D-A87E-8CCF209EC36AQ34259686-2455778E-2FC0-416B-B0F3-61FC1BABD7D9Q34369800-1B16F0A3-0CFD-48BA-82A6-E361F70A7E85Q34422543-A9DAB0DF-6827-46C4-9825-0B2E5524FC13Q35153809-2F99CB56-7A6D-476B-99F3-EF5244E2118FQ35184667-DA06093E-A610-4E2A-86ED-A180BACF9ACEQ35223947-9FDF0A84-70BA-435D-B477-C0044653080DQ35525461-ED0C02EA-35E7-4188-B5D0-35EDC2A4E524Q35588804-9F3E91A5-8D76-406C-83E7-8A85C0EAE799Q35604039-84377315-EC3F-4A31-B623-A884787AF5DEQ35665096-F9D76658-2033-4AC1-8C87-FAA872648B48Q35679620-DC86A81A-48EC-4AEA-B409-9C8682D1A314Q36021536-C88B5316-B914-4DFC-B9FE-3C183A0C6AD7Q36398704-9F033818-601B-4742-93C0-CA0A41F7F551Q36528733-7B1628BC-C7BE-4714-9DEA-D95A8B9BA89DQ36531585-E54C2BC0-D3A0-4F5A-A066-AAC6DBCB2662Q36612560-E970B747-404C-40AE-8C6E-D52D797A7E50Q36615092-A2482039-476D-4068-B354-A1527F778160Q37117167-A79E561B-9720-4C01-BE3E-6B0437826BC3Q37356389-8B5FF6DD-1835-45DC-AA80-2267658FD681Q37624268-6925DD0E-427D-40AA-B0B5-BD6EFBF42382Q38022455-F30CE98A-9153-4930-99C3-853D65AD6AB2Q38210641-8153629A-CA04-4780-A65E-39BECC49C9A0Q38406849-4CABCE71-DFB4-4CB0-8569-F318E1CFB67EQ45723732-96D34266-CCCD-4E56-8B98-DF44440842EAQ45989594-578C8905-EDBE-4C44-86E1-B033177B8766Q46060624-EB3F95AC-5055-428A-AEAE-83BC69A6E7C3Q46181268-2FC89DE4-B9AC-42CE-84F3-8549C185982FQ48134074-326845DB-FF33-4196-823A-2E6B3CAA1BF3Q48182006-560DDFD7-42EC-4C39-B456-D9490F5DF26CQ48557692-711730BA-DCAA-400F-AEDC-7279B20BD51F
P2860
Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Late effects in survivors of H ...... row transplant survivor study.
@ast
Late effects in survivors of H ...... row transplant survivor study.
@en
type
label
Late effects in survivors of H ...... row transplant survivor study.
@ast
Late effects in survivors of H ...... row transplant survivor study.
@en
prefLabel
Late effects in survivors of H ...... row transplant survivor study.
@ast
Late effects in survivors of H ...... row transplant survivor study.
@en
P2093
P2860
P1476
Late effects in survivors of H ...... row transplant survivor study.
@en
P2093
Andrea Carter
Can-Lan Sun
K Scott Baker
Kirsten K Ness
Linda J Burns
Liton Francisco
Navneet S Majhail
Smita Bhatia
Stephen J Forman
P2860
P304
P356
10.1016/J.BBMT.2007.06.003
P577
2007-07-20T00:00:00Z